scispace - formally typeset
M

Marielle Scherrer-Crosbie

Researcher at University of Pennsylvania

Publications -  183
Citations -  12477

Marielle Scherrer-Crosbie is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Ejection fraction & Heart failure. The author has an hindex of 48, co-authored 167 publications receiving 10663 citations. Previous affiliations of Marielle Scherrer-Crosbie include Massachusetts Institute of Technology & University of Alabama at Birmingham.

Papers
More filters
Journal ArticleDOI

Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

TL;DR: The noninvasive evaluation of LVEF has gained importance, and notwithstanding the limitations of the techniques used for its calculation, has emerged as the most widely used strategy for monitoring the changes in cardiac function, both during and after the administration of potentially car- diotoxic cancer treatment.
Journal ArticleDOI

Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

TL;DR: The non-invasive evaluation of LVEF has gained importance, and notwithstanding the limitations of the techniques used for its calculation, has emerged as the most widely used strategy for monitoring the changes in cardiac function, both during and after the administration of potentially cardiotoxic cancer treatment.
Journal ArticleDOI

Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice

TL;DR: This phenotype constitutes the first murine model to demonstrate distal coronary arteriosclerosis associated with evidence of myocardial ischemia, infarction, and heart failure and introduces coronary disease and an array of cardiovascular complications, including spontaneous aortic aneurysm and dissection.
Journal ArticleDOI

Early detection and prediction of cardiotoxicity in chemotherapy-treated patients.

TL;DR: Cardiac troponin plasma concentrations and longitudinal strain predict the development of cardiotoxicity in patients treated with anthracyclines and trastuzumab, and the 2 parameters may be useful to detect chemotherapy-treated patients who may benefit from alternative therapies, potentially decreasing the incidence ofCardiotoxicity and its associated morbidity and mortality.